Neoadjuvant epirubicin, gemcitabine and docetaxel for primary breast cancer: long-term survival data and major prognostic factors based on two consecutive neoadjuvant phase I/II trials.
about
The Neo-Bioscore Update for Staging Breast Cancer Treated With Neoadjuvant Chemotherapy: Incorporation of Prognostic Biologic Factors Into Staging After Treatment.Validation of the CPS + EG Staging System for Disease-Specific Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.Neoadjuvant chemotherapy for different molecular breast cancer subtypes: a retrospective study in Russian population.
P2860
Neoadjuvant epirubicin, gemcitabine and docetaxel for primary breast cancer: long-term survival data and major prognostic factors based on two consecutive neoadjuvant phase I/II trials.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Neoadjuvant epirubicin, gemcit ...... neoadjuvant phase I/II trials.
@ast
Neoadjuvant epirubicin, gemcit ...... neoadjuvant phase I/II trials.
@en
type
label
Neoadjuvant epirubicin, gemcit ...... neoadjuvant phase I/II trials.
@ast
Neoadjuvant epirubicin, gemcit ...... neoadjuvant phase I/II trials.
@en
prefLabel
Neoadjuvant epirubicin, gemcit ...... neoadjuvant phase I/II trials.
@ast
Neoadjuvant epirubicin, gemcit ...... neoadjuvant phase I/II trials.
@en
P2093
P2860
P356
P1476
Neoadjuvant epirubicin, gemcit ...... neoadjuvant phase I/II trials.
@en
P2093
Christof Sohn
Dirk Jäger
Frederik Marmé
Julia Aigner
Justo Lorenzo Bermejo
Peter Sinn
P2860
P304
P356
10.1002/IJC.28094
P577
2013-03-16T00:00:00Z